Table 1.
Characteristics of patients in the pilot study (N=80).
| Characteristics | Australian patients | French patients | |||||||||
|
|
Total, n (%) | Value | Total, n (%) | Value | |||||||
| Demographics, median (range) | |||||||||||
|
|
Age (years) | 41 (51) | 58 (50-64) | 39 (49) | 52 (44-60) | ||||||
|
|
Duration HIV (months) | 34 (43) | 228 (153-312) | 36 (45) | 126 (69-240) | ||||||
| Sex, n (%) | 41 (51) |
|
36 (45) |
|
|||||||
|
|
Male |
|
37 (90) |
|
29 (81) | ||||||
|
|
Female |
|
4 (10) |
|
7 (19) | ||||||
| Ethnicity, n (%) | 38 (48) |
|
36 (45) |
|
|||||||
|
|
White |
|
33 (87) |
|
27 (75) | ||||||
|
|
Asian |
|
4 (10) |
|
1 (3) | ||||||
|
|
Middle Eastern |
|
1 (3) |
|
0 (0) | ||||||
|
|
African |
|
0 (0) |
|
7 (19) | ||||||
|
|
Latinx |
|
0 (0) |
|
1 (3) | ||||||
| Mode of transmission, n (%) | 33(41) |
|
36 (45) |
|
|||||||
|
|
MSMa |
|
27 (82) |
|
22 (61) | ||||||
|
|
Heterosexual |
|
6 (18) |
|
14 (39) | ||||||
| Employment, n (%) | 41 (51) |
|
19 (34) |
|
|||||||
|
|
Employed |
|
23 (56) |
|
12 (63) | ||||||
|
|
Not employed |
|
18 (44) |
|
7 (37) | ||||||
| Clinical variables | |||||||||||
|
|
CD4 T cells, median (range) | 31 (39) | 703 (458-946) | 36 (45) | 610 (480-872) | ||||||
|
|
HIV viral load, n (%) | ||||||||||
|
|
|
>20 copies/ml | 31 (39) | N/Ab | 33 (41) | 33 (92) | |||||
|
|
|
<20 copies/ml | 31 (39) | 31 (100) | 3 (4) | 3 (8) | |||||
|
|
HBV-HCV coinfection, n (%) | 31 (39) | 0 (0) | 35 (44) | 10 (29) | ||||||
aMSM: men who have sex with men.
bN/A: Not applicable.